APA (7th ed.) Citation

NM, A., IH, H., MA, A., HN, A., & AM, M. (2016). Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats. Drug design, development and therapy, 10, 2095. https://doi.org/10.2147/DDDT.S109287

Chicago Style (17th ed.) Citation

NM, Al-Rasheed, Hasan IH, Al-Amin MA, Al-Ajmi HN, and Mahmoud AM. "Sitagliptin Attenuates Cardiomyopathy by Modulating the JAK/STAT Signaling Pathway in Experimental Diabetic Rats." Drug Design, Development and Therapy 10 (2016): 2095. https://doi.org/10.2147/DDDT.S109287.

MLA (9th ed.) Citation

NM, Al-Rasheed, et al. "Sitagliptin Attenuates Cardiomyopathy by Modulating the JAK/STAT Signaling Pathway in Experimental Diabetic Rats." Drug Design, Development and Therapy, vol. 10, 2016, p. 2095, https://doi.org/10.2147/DDDT.S109287.